ISSN: 1885-5857 Impact factor 2025 4.2
Corrected proofs Journal pre-proofs

Special article
Current indications for cardiac magnetic resonance and cardiac computed tomography: a position statement from the Cardiovascular Imaging Association of the Spanish Society of Cardiology

Indicaciones actuales de resonancia magnética y tomografía computarizada cardiacas. Documento de posicionamiento de la Asociación de Imagen Cardiaca de la Sociedad Española de Cardiología

José Antonio Parada-BarciaaÁlvaro Rodríguez-PérezbRocío Eiros-BachillercMarinela Chaparro-MuñozdJosé Rodríguez-PalomareseCovadonga Fernández-GolfinfManuel Barreiro-Péreza
https://doi.org/10.1016/j.rec.2026.06.015
Abstract

Cardiac magnetic resonance and cardiac computed tomography have become essential imaging modalities in the evaluation of patients with a wide spectrum of cardiovascular diseases, providing valuable anatomical and functional information for clinical decision-making, prognostic stratification, and therapeutic planning. Their indications and clinical applications have expanded considerably in recent years; however, accessibility and implementation remain uneven among health care settings. To facilitate and promote access to these techniques, the Cardiovascular Imaging Association of the Spanish Society of Cardiology has prepared this position statement, which brings together, in a structured format, the main recommendations of the European Society of Cardiology regarding their use. The document promotes the implementation of these modalities through specialized training for health care professionals, the use of well-established indications, and the prioritization of applications with high clinical impact in cardiovascular medicine.

Keywords

Cardiac magnetic resonance
Cardiac computed tomography
Cardiovascular imaging
Clinical practice guidelines
European Society of Cardiology

Abbreviations

CMR
CPG
CT

Identify yourself

Not yet a subscriber to the journal?

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960
References
[1]
Sociedad Española de Cardiología.
Proyecto RECALCAR: La atención al paciente en las unidades de cardiología del Sistema Nacional de Salud. Informe RECALCAR 2017.
Madrid, España: Sociedad Española de Cardiología;, (2017),
[2]
Sociedad Española de, Cardiología, Informe, RECALCAR., 2025.
Recursos, actividad y calidad asistencial en cardiología en el Sistema Nacional de Salud.
Madrid, España: Sociedad Española de Cardiología, (2025),
[3]
Ministerio de Sanidad. Plan INVEAT (Inversión en Equipos de Alta Tecnología). Available at: https://www.sanidad.gob.es/profesionales/prestacionesSanitarias/PlanINVEAT/home.htm. Accessed 15 Feb 2026.
[4]
J. Agüero Ramón-Lin, A. Martínez-Monzonis, C. Fernández-Golfín, M. Alamar Cervera, M. Barreiro-Pérez.
IV informe de actividad y recursos de la Asociación de Imagen Cardiaca de la Sociedad Española de Cardiología (2022).
REC Cardioclinics., (2025), 60 pp. 43-52
[5]
M. Barreiro-Pérez, M. Delgado Ortega, L. Galián-Gay, C. Jiménez López-Guarch, A. Martínez-Monzonis, L.J. Jiménez-Borreguero.
Spanish Cardiovascular Imaging Registry Third Official Report from the Cardiovascular Imaging Association of the Spanish Society of Cardiology (2020).
Rev Esp Cardiol., (2022), 75 pp. 351-353
[6]
L. Monti, F. Ricci, A. Baggiano, et al.
Current trends and challenges in the clinical use of cardiovascular magnetic resonance: a survey from the Italian Society of Cardiology.
Eur Heart J Imaging Methods Pract., (2025), 3
[7]
A. Choi, D. Thomas, J. Lee, et al.
2020 SCCT Guideline for Training Cardiology and Radiology Trainees as Independent Practitioners (Level II) and Advanced Practitioners (Level III) in Cardiovascular Computed Tomography: A Statement from the Society of Cardiovascular Computed Tomography.
JACC Cardiovasc Imaging., (2021), 14 pp. 272-287
[8]
E. Nguyen, K. Ordovas, P. Herbst, et al.
Competency based curriculum for cardiovascular magnetic resonance: A position statement of the Society for Cardiovascular Magnetic Resonance.
J Cardiovasc Magn Reson., (2024), 26
[9]
C. Vrints, F. Andreotti, K. Koskinas, et al.
2024 ESC Guidelines for the management of chronic coronary syndromes.
Eur Heart J., (2024), 45 pp. 3415-3537
[10]
R. Byrne, X. Rossello, J. Coughlan, et al.
2023 ESC Guidelines for the management of acute coronary syndromes.
Eur Heart J., (2023), 44 pp. 3720-3826
[11]
F. Mach, K. Koskinas, J. Roeters van Lennep, et al.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Eur Heart J., (2025), 46 pp. 4359-4378
[12]
A. Pelliccia, S. Sharma, M. Bäck, et al.
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.
Eur Heart J., (2021), 42 pp. 17-96
[13]
S. Halvorsen, J. Mehilli, S. Cassese, et al.
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
Eur Heart J., (2022), 43 pp. 3826-3924
[14]
F. Neumann, M. Sousa-Uva, A. Ahlsson, et al.
2018 ESC/EACTS Guidelines on myocardial revascularization.
Eur Heart J., (2019), 40 pp. 87-165
[15]
L. Mazzolai, G. Teixido-Tura, S. Lanzi, et al.
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.
Eur Heart J., (2024), 45 pp. 3538-3700
[16]
J. De Backer, K. Haugaa, N. Hasselberg, et al.
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy.
Eur Heart J., (2025), 46 pp. 4462-4568
[17]
E. Arbelo, A. Protonotarios, J. Gimeno, et al.
2023 ESC Guidelines for the management of cardiomyopathies.
Eur Heart J., (2023), 44 pp. 3503-3626
[18]
T. McDonach, M. Metra, M. Adamo, et al.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Eur Heart J., (2021), 42 pp. 3599-3726
[19]
K. Zeppenfeld, J. Tfelt-Hansen, M. de Riva, et al.
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
Eur Heart J., (2022), 43 pp. 3997-4126
[20]
A. Lyon, T. López-Fernández, L. Couch, 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS), et al.
Eur Heart J., (2022), 43 pp. 4229-4361
[21]
J. Schulz-Menger, V. Collini, J. Gröschel, et al.
2025 ESC Guidelines for the management of myocarditis and pericarditis.
Eur Heart J., (2025), 46 pp. 3952-4041
[22]
M. Humbert, G. Kovacs, M. Hoeper, et al.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J., (2022), 43 pp. 3618-3713
[23]
F. Pratz, M. Borger, J. Lanz, et al.
2025 ESC/EACTS Guidelines for the management of valvular heart disease.
Eur Heart J., (2025), 46 pp. 4635-4736
[24]
V. Delgado, N. Marsan, S. Waha, et al.
2023 ESC Guidelines for the management of endocarditis.
Eur Heart J., (2023), 44 pp. 3948-4042
[25]
H. Baumgartner, J. De Backer, S. Babu-Narayan, et al.
2020 ESC Guidelines for the management of adult congenital heart disease.
Eur Heart J., (2021), 42 pp. 563-645
Copyright © 2026. Sociedad Española de Cardiología